Distillate Capital Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-89,666
Closed -$20.8M 123
2024
Q4
$20.8M Sell
89,666
-8,261
-8% -$1.9M 1.02% 28
2024
Q3
$21.6M Sell
97,927
-1,113
-1% -$230K 1.08% 36
2024
Q2
$19.5M Buy
+99,040
New +$20.5M 1.03% 27
2021
Q3
Sell
-14,676
Closed -$3.12M 115
2021
Q2
$3.12M Buy
14,676
+818
+6% +$173K 0.87% 45
2021
Q1
$2.83M Buy
13,858
+3,640
+36% +$717K 0.92% 36
2020
Q4
$1.82M Buy
+10,218
New +$1.74M 0.87% 47

Other funds holding CME

Distillate Capital Partners's CME Position: Q1 2025 in Review

Distillate Capital Partners sold out of CME Group (CME) in Q1 2025, closing a stake of 89,666 shares — an estimated $20.8M sold.

Distillate Capital Partners first reported a position in CME in Q4 2020 and held it in 6 quarters. The position peaked at $21.6M in Q3 2024. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

  • Distillate Capital Partners reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
  • Distillate Capital Partners sold 89,666 CME Group shares in Q1 2025, an estimated $20.8M.
  • Distillate Capital Partners first reported a position in CME Group in Q4 2020 and held it in 6 quarters.
  • Distillate Capital Partners's CME Group position peaked at $21.6M in Q3 2024.
  • 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Distillate Capital Partners's 13F filing for Q1 2025, filed 13 May 2025.